No Data
No Data
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
H.C. Wainwright Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Maintains Target Price $8
Guggenheim Maintains Buy on ADC Therapeutics, Lowers Price Target to $7
ADC Therapeutics Analyst Ratings
ADC Therapeutics Earnings Call: Optimism Amid Challenges